Tag: Financing

Source Bioscience to Invest €585,000 in Irish Microbiology Labs

The UK-based lab service and product provider will spend $650,000 to improve turnaround times for Irish customers. Source Bioscience has invested €585,000 (US$650,000) in microbiology and sterility...

UK Government Invests over £130 mln to Tackle Serious Diseases

The UK government has announced an investment of over £130 million for new tech to tackle cancer and debilitating illnesses. The news means that thousands of NHS patients could receive faster diagn...

Sanofi Will Pay to Lexicon for Partnership Termination

Lexicon Pharmaceuticals Inc said on Tuesday that France’s Sanofi SA will pay the drugmaker $260 million for the termination of their partnership to develop diabetes drug Zynquista. Shares of Lexico...

Strides to Acquire Majority Stake in Fairmed

Strides Pharma Science Limited has announced its acquisition of majority stake in Fairmed Healthcare AG. Strides Pharma Global Pvt Ltd (SPG) is a step down subsidiary of Strides Pharma Science Limi...

Apexan Pharmaceuticals Got $2.3 mln from NHLBI for Study

Apexan Pharmaceuticals has announced that The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded a $2.3 million grant to Dr. Reuben Kapur and Dr. M...

ADC Therapeutics to Complete Series E Financing Expansion

ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), announced that it has closed a $76 million expansion of its...

Immuno-Oncology Startup Oncologie Raised $80 million in Venture Financing

biotech-lab
Boston and Shanghai, immuno-oncology startup Oncologie has bagged $80 million in venture financing. The capital will bankroll three clinical-stage programs, licensing deals and the development of the ...

Schrödinger Raised $110m for Expansion of its Drug-Discovery Pipeline

car-t
Schrödinger announced that several new investors have joined its latest funding round, which was completed with a total raise of $110 million to support continued advancement of the company’s industry...

Gilead Sciences Posted Smallest Year-Over-Year Decline of Drugs Sales Since 2015

gilead sciences
Gilead Sciences' hepatitis C treatments appeared stable Thursday as the biotech titan posted its smallest year-over-year decline for the drugs in three years. Meanwhile, Gilead earnings beat first-qua...

Gedeon Richter Underwrites $5mln Convertible Notes of Prima-Temp

Hungarian drugmaker Gedeon Richter said it has underwritten USD 5 million of convertible notes issued by Prima-Temp, a U.S. company that is developing a smart fertility sensor. Richter noted that i...

AbCellera to Initiate Global Health Research

AbCellera announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research. The funding, totaling $4.8 M, will support a series of scientific colla...

Pfizer and Vivet Collaborate to Fight Rare Disease

Vivet Therapeutics, a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need, and Pfizer Inc. announced ...

Takeda Looks to Cut Debt after M&A Shire

takeda hq tokyo
Takeda Pharmaceutical Co. is planning a sale of its Tachosil brand of surgical patches and sealants as it looks to cut debt after its $62 billion takeover of Shire Plc, people familiar with the matter...

Merck Starts Tender Offer to Buy Immune Design

Merck, known as MSD outside the United States and Canada, is commencing, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Immune Design. On Feb. 21, 2019...

Urovant Sciences and Hercules Capital Signed $100m Debt Deal

Urovant Sciences, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, announced it has entered into a debt financing agre...

Med Pricing Pushes People into Poverty

Spending on health is growing faster than the rest of the global economy, accounting for 10% of global gross domestic product (GDP). A new report on global health expenditure from the World Health Org...